|
| |
| | | 69956 | | 07.10.2025 | | Gebro Pharma AG | | | | | | | 06.10.2030 | | | | | | 10000. | | | | 01.07.10. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Dalingo 82.5 mg | Retardtabletten | Retard-Tabletten (Pregabalin 82.5 mg) | N02BF02 | PI | | 02 | Dalingo 165 mg | Retardtabletten | Retard-Tabletten (Pregabalin 165 mg) | N02BF02 | PI | | 03 | Dalingo 330 mg | Retardtabletten | Retard-Tabletten (Pregabalin 330 mg) | N02BF02 | PI |
|
|
|
